Katayama I - Search Results

1

Periostin in the pathogenesis of skin diseases.

Murota H, Lingli Y, Katayama I. Murota H, et al. Among authors: katayama i. Cell Mol Life Sci. 2017 Dec;74(23):4321-4328. doi: 10.1007/s00018-017-2647-1. Epub 2017 Sep 15. Cell Mol Life Sci. 2017. PMID: 28916993 Review.

2

Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma.

Yang L, Serada S, Fujimoto M, Terao M, Kotobuki Y, Kitaba S, Matsui S, Kudo A, Naka T, Murota H, Katayama I. Yang L, et al. Among authors: katayama i. PLoS One. 2012;7(7):e41994. doi: 10.1371/journal.pone.0041994. Epub 2012 Jul 24. PLoS One. 2012. PMID: 22911870 Free PMC article.

3

Histamine contributes to tissue remodeling via periostin expression.

Yang L, Murota H, Serada S, Fujimoto M, Kudo A, Naka T, Katayama I. Yang L, et al. Among authors: katayama i. J Invest Dermatol. 2014 Aug;134(8):2105-2113. doi: 10.1038/jid.2014.120. Epub 2014 Feb 27. J Invest Dermatol. 2014. PMID: 24577408 Free article.

4

Periostin accelerates human malignant melanoma progression by modifying the melanoma microenvironment.

Kotobuki Y, Yang L, Serada S, Tanemura A, Yang F, Nomura S, Kudo A, Izuhara K, Murota H, Fujimoto M, Katayama I, Naka T. Kotobuki Y, et al. Among authors: katayama i. Pigment Cell Melanoma Res. 2014 Jul;27(4):630-9. doi: 10.1111/pcmr.12245. Epub 2014 Apr 22. Pigment Cell Melanoma Res. 2014. PMID: 24674392 Clinical Trial.

5

Sweat in the pathogenesis of atopic dermatitis.

Murota H, Yamaga K, Ono E, Katayama I. Murota H, et al. Among authors: katayama i. Allergol Int. 2018 Oct;67(4):455-459. doi: 10.1016/j.alit.2018.06.003. Epub 2018 Aug 3. Allergol Int. 2018. PMID: 30082151 Free article. Review.

6

New aspect of anti-inflammatory action of lipo-prostaglandinE1 in the management of collagen diseases-related skin ulcer.

Murota H, Kotobuki Y, Umegaki N, Tani M, Katayama I. Murota H, et al. Among authors: katayama i. Rheumatol Int. 2008 Sep;28(11):1127-35. doi: 10.1007/s00296-008-0589-5. Epub 2008 May 7. Rheumatol Int. 2008. PMID: 18461292

7

Emedastine difumarate: a review of its potential ameliorating effect for tissue remodeling in allergic diseases.

Murota H, Katayama I. Murota H, et al. Among authors: katayama i. Expert Opin Pharmacother. 2009 Aug;10(11):1859-67. doi: 10.1517/14656560903078410. Expert Opin Pharmacother. 2009. PMID: 19558341 Review.

8

Tumor necrosis factor-alpha processing inhibitor-1 inhibits skin fibrosis in a bleomycin-induced murine model of scleroderma.

Terao M, Murota H, Kitaba S, Katayama I. Terao M, et al. Among authors: katayama i. Exp Dermatol. 2010 Jan;19(1):38-43. doi: 10.1111/j.1600-0625.2009.00973.x. Epub 2009 Sep 16. Exp Dermatol. 2010. PMID: 19758314

9

The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab.

Shima Y, Kuwahara Y, Murota H, Kitaba S, Kawai M, Hirano T, Arimitsu J, Narazaki M, Hagihara K, Ogata A, Katayama I, Kawase I, Kishimoto T, Tanaka T. Shima Y, et al. Among authors: katayama i. Rheumatology (Oxford). 2010 Dec;49(12):2408-12. doi: 10.1093/rheumatology/keq275. Epub 2010 Sep 5. Rheumatology (Oxford). 2010. PMID: 20819796 Free PMC article.

10

A case of disseminated DLE complicated by atopic dermatitis and Sjögren's syndrome: link between hypohidrosis and skin manifestations.

Matsui S, Kitaba S, Itoi S, Kijima A, Murota H, Tani M, Katayama I. Matsui S, et al. Among authors: katayama i. Mod Rheumatol. 2011 Feb;21(1):101-5. doi: 10.1007/s10165-010-0352-0. Epub 2010 Sep 8. Mod Rheumatol. 2011. PMID: 20824298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

853 results

Search Page